Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.

Original languageEnglish (US)
Pages (from-to)910-912
Number of pages3
JournalAmerican Journal of Psychiatry
Volume143
Issue number7
DOIs
StatePublished - Jan 1 1986

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this